Figure : Global Atrial Fibrillation Surgery Market By Region
Global Atrial Fibrillation Surgery
Market is expected to grow at a CAGR between 14.0% and 14.5% over the
Forecast period 2016 to 2022. Atrial Fibrillation Surgery Market is the most common type of arrhythmia
that causes an irregular and often fast heart rhythm. Globally, the
atrial fibrillation has been increasing over the past few years. The
development in the surgical ablation technology and better results of
these procedures are driving the overall number of surgical ablation
procedures. The Global Atrial Fibrillation Surgery market is expected to
be primarily driven by Factors such as Rising geriatric population
worldwide, and Favorable results exhibited by clinical trials aimed at
treating atrial fibrillation and Rising prevalence of disorders. However, the growth in the global atrial fibrillation surgery market is
likely to be restrained by factors such as Stringent product approval
regulations by agencies such as FDA, CE and European Medicines Agency.
The development in the surgical ablation technology and better results
of these procedures are driving the overall number of surgical ablation
The Atrial Fibrillation Surgery Market is segmented on the basis of
Product, Procedures. On the basis of surgical procedures the market is
segmented as catheter ablation and surgical ablation. Furthermore, on
the basis of products the market is segmented as
The regions covered in the report include North America, Europe,
Asia-Pacific, and Rest of the World .North America region covers the
country markets such as U.S., Canada, and Mexico. Furthermore Europe
includes the country markets such as Germany, U.K., France, Spain, and
Rest of Europe. The Asia-Pacific region covers the analysis of countries
such as China Japan India Australia/New Zealand and Rest of APAC.
Among the geographies North America is expected to be the largest market
for Atrial Fibrillation Surgery Market over the Forecast period 2016 to
2022. Furthermore Asia-Pacific is expected to grow at the highest CAGR
over the forecast period.
• Biosense Webster,Inc.
• Medtronic, Inc.
• St. Jude Medical, Inc.
• Boston Scientific Corporation
• Atricure, Inc.
• Cardiofocus, Inc.
• Ncontact, Inc.
• Carima, Inc.
• Biotroik Se & Co.Kg,
The report provides deep insights on demand forecasts, market trends and
micro and macro indicators. In addition, this report provides insights
on the factors that are driving and restraining the demand globally as
well as regionally. Moreover, IGR- Growth Matrix Analysis given in the
report brings an insight on the investment areas that existing or new
market players can consider.
The report provides insights into the market using analytical tools such
as Porter’s five forces analysis and value chain analysis of Atrial
Fibrillation Surgery Market. Further, the study highlights current
market trends and provides forecast from 2016 to 2022. We also have
highlighted future trends in the Atrial Fibrillation Surgery Market that
will impact the demand during the forecast period.
The IGR- Growth Matrix Analysis provided in this report highlights key
investing markets in the world. Moreover, the competitive analysis given
in each regional market brings an insight on the market share of the
leading players. Additionally, the analysis highlights rise and fall in
the market shares of the key players in the market.
The report also provides in depth
analysis of regulatory framework pertaining to Atrial Fibrillation
Surgery Market. This will help the companies to understand the
regulatory compliances, supports, barriers in the Atrial Fibrillation
Surgery market. This section highlights key amendments and their
implication on Atrial Fibrillation Surgery Atrial Fibrillation Surgery
market in the short run as well as in the long run.This report will help
manufacturers, suppliers and distributors to understand the present and
future trends in this market and formulate their strategies
1. Report Overview
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Atrial Fibrillation Surgery Market Overview
3.2 Market Dynamics
3.7 Porter’s Five Forces Analysis
3.8 IGR – Growth Matrix Analysis
3.9 Competitive Landscape in Global Atrial Fibrillation Surgery Market
3.10 : Regulatory Framework analysis by region
3.10.1: North America
3.10.3 RoW (Including APAC, and LATAM)
4. Global Atrial Fibrillation Surgery Market by Product
4.2 Catheter Ablation products
4.3 Surgical Ablation products
5. Global Atrial Fibrillation Surgery Market by Procedures
5.2 Catheter Ablation procedures
5.3 Surgical Ablation procedures
6. Global Atrial Fibrillation Surgery Market by Region
6.2 North America
6.2.1 North America Atrial Fibrillation Surgery Market by Product
6.2.2 North America Atrial Fibrillation Surgery Market by Procedures
6.2.3 North America Atrial Fibrillation Surgery Market by country
6.3.1 Europe Atrial Fibrillation Surgery Market by Product
6.3.2 Europe Atrial Fibrillation Surgery Market by Procedures
6.3.3 Europe Atrial Fibrillation Surgery Market by country
6.4.1 Asia-Pacific Atrial Fibrillation Surgery Market by Product
6.4.2 Asia-Pacific Atrial Fibrillation Surgery Market by Procedures
6.4.3 Asia-Pacific Atrial Fibrillation Surgery Market by country
6.5 Rest of the World
6.5.1 Rest of the World Atrial Fibrillation Surgery Market by Product
6.5.2 Rest of the World Atrial Fibrillation Surgery Market by Procedures
7. Company Profiles
7.1 Biosense Webster, Inc.
7.2 Medtronic, Inc.
7.3 St. Jude Medical, Inc.
7.4 Boston Scientific Corporation
7.5 Atricure, Inc.
7.6 Cardiofocus, Inc.
7.7 Ncontact, Inc.
7.8 Carima, Inc.
7.9 Biotroik Se & Co.Kg